Abivax SA
PAR:ABVX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rational AG
XETRA:RAA
|
DE |
|
AMREP Corp
NYSE:AXR
|
US |
|
O
|
Organizacion Cultiba SAB de CV
BMV:CULTIBAB
|
MX |
|
Xpeng Inc
NYSE:XPEV
|
CN |
Abivax SA
Operating Expenses
Abivax SA
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Abivax SA
PAR:ABVX
|
Operating Expenses
-€233.9m
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
|
Valneva SE
PAR:VLA
|
Operating Expenses
-€142m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-11%
|
|
|
G
|
Genfit SA
PAR:GNFT
|
Operating Expenses
-€71.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-13%
|
|
|
Inventiva SA
PAR:IVA
|
Operating Expenses
-€102.9m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
DBV Technologies SA
PAR:DBV
|
Operating Expenses
-$125.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-14%
|
|
|
Eurobio Scientific SA
PAR:ALERS
|
Operating Expenses
-€63.8m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-13%
|
|
Abivax SA
Glance View
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.
See Also
What is Abivax SA's Operating Expenses?
Operating Expenses
-233.9m
EUR
Based on the financial report for Jun 30, 2025, Abivax SA's Operating Expenses amounts to -233.9m EUR.
What is Abivax SA's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-50%
Over the last year, the Operating Expenses growth was -9%. The average annual Operating Expenses growth rates for Abivax SA have been -73% over the past three years , -50% over the past five years .
